Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder

• DOI: 10.1176/appi.ajp.2013.12010127
• Publication Date: 2013-07-12T04:30:55Z
• Authors: L. Fredrik Jarskog; Robert M. Hamer; Diane J. Catellier; Dawn D. Stewart; Lisa LaVange; Neepa Ray; Lauren H. Golden; Jeffrey A. Lieberman; T. Scott Stroup
• Keywords: Adult; Glycated Hemoglobin; Male; 2. Zero hunger; Dose-Response Relationship, Drug; Middle Aged; Weight Gain; Metformin; Body Mass Index; 3. Good health; Treatment Outcome; Double-Blind Method; Metabolic Diseases; Psychotic Disorders; Schizophrenia; Humans; Hypoglycemic Agents; Female; Obesity; Drug Monitoring; Antipsychotic Agents

The purpose of this study was to determine whether metformin promotes weight loss in overweight out-patients with chronic schizophrenia or schizoaffective disorder.